REC 0545

Drug Profile

REC 0545

Latest Information Update: 24 Feb 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Recordati
  • Class
  • Mechanism of Action Serotonin 1A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Genitourinary disorders; Overactive bladder

Most Recent Events

  • 31 Dec 2007 Discontinued - Phase-II for Overactive bladder in Europe (unspecified route)
  • 31 Dec 2007 Discontinued - Preclinical for Genitourinary disorders in Europe (unspecified route)
  • 14 Nov 2006 Final results from a phase IIa clinical trial in patients with hyperactive bladder have been added to the Genitourinary disorders therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top